Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 36
2003 54
2004 89
2005 123
2006 144
2007 192
2008 244
2009 307
2010 325
2011 430
2012 486
2013 649
2014 763
2015 873
2016 925
2017 1038
2018 1224
2019 1334
2020 1645
2021 1716
2022 2086
2023 2047
2024 805

Text availability

Article attribute

Article type

Publication date

Search Results

15,524 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for china wei li
Search for Chia-Wai Li instead (1 results)
Clinical Characteristics of Coronavirus Disease 2019 in China.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Guan WJ, et al. Among authors: wei l. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28. N Engl J Med. 2020. PMID: 32109013 Free PMC article.
BACKGROUND: Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of the affected patients. ...(Funded by the National Health Commission of China …
BACKGROUND: Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, …
Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database study.
Zhao H, Wei L, Li H, Zhang M, Cao B, Bian J, Zhan S. Zhao H, et al. Among authors: wei l. Lancet Infect Dis. 2021 Jun;21(6):847-857. doi: 10.1016/S1473-3099(20)30596-X. Epub 2021 Jan 27. Lancet Infect Dis. 2021. PMID: 33515511
INTERPRETATION: Inappropriate antibiotic prescribing was highly prevalent nationwide in China. Over half of the antibiotic prescriptions were inappropriate in secondary-level and tertiary-level hospitals, suggesting an urgent need for outpatient antibiotic stewardship aime …
INTERPRETATION: Inappropriate antibiotic prescribing was highly prevalent nationwide in China. Over half of the antibiotic prescripti …
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.
Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ, Li L, Chen PY, Sang L, Wang W, Li JF, Li CC, Ou LM, Cheng B, Xiong S, Ni ZY, Xiang J, Hu Y, Liu L, Shan H, Lei CL, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Cheng LL, Ye F, Li SY, Zheng JP, Zhang NF, Zhong NS, He JX; China Medical Treatment Expert Group for COVID-19. Guan WJ, et al. Among authors: wei l. Eur Respir J. 2020 May 14;55(5):2000547. doi: 10.1183/13993003.00547-2020. Print 2020 May. Eur Respir J. 2020. PMID: 32217650 Free PMC article.
METHODS: We analysed data from 1590 laboratory confirmed hospitalised patients from 575 hospitals in 31 provinces/autonomous regions/provincial municipalities across mainland China between 11 December 2019 and 31 January 2020. We analysed the composite end-points, which co …
METHODS: We analysed data from 1590 laboratory confirmed hospitalised patients from 575 hospitals in 31 provinces/autonomous regions/provinc …
International expert consensus on immunotherapy for early-stage non-small cell lung cancer.
Liang W, Cai K, Cao Q, Chen C, Chen H, Chen J, Chen KN, Chen Q, Chu T, Dong Y, Fan J, Fang W, Fu J, Fu X, Gao S, Ge D, Geng G, Geng Q, He J, Hu J, Hu J, Hu WD, Jiang F, Jiang T, Jiao W, Li HC, Li Q, Li S, Li S, Li X, Liao YD, Liu C, Liu H, Liu Y, Lu Z, Luo Q, Ma H, Pan X, Qiao G, Ren S, Shen W, Song Y, Sun D, Wang G, Wang J, Wang M, Wang Q, Wang WX, Wei L, Wu M, Wu N, Xia H, Xu SD, Yang F, Yang K, Yang Y, Yu F, Yu ZT, Yue DS, Zhang L, Zhang W, Zhang Z, Zhao G, Zhao J, Zhao X, Zhou C, Zhou Q, Zhu K, Zhu Y, Hida T, Dempke WCM, Rossi A, de Perrot M, Ramirez RA, Provencio M, Lee JM, Passaro A, Spaggiari L, Spicer J, Girard N, Forde PM, Mok TSK, Cascone T, He J. Liang W, et al. Among authors: wei l. Transl Lung Cancer Res. 2022 Sep;11(9):1742-1762. doi: 10.21037/tlcr-22-617. Transl Lung Cancer Res. 2022. PMID: 36248334 Free PMC article. Review. No abstract available.
Advanced nanomaterial for prostate cancer theranostics.
Hao B, Wei L, Cheng Y, Ma Z, Wang J. Hao B, et al. Among authors: wei l. Front Bioeng Biotechnol. 2022 Nov 1;10:1046234. doi: 10.3389/fbioe.2022.1046234. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36394009 Free PMC article. Review.
15,524 results
You have reached the last available page of results. Please see the User Guide for more information.